in response to "
To those of you who deal with orthopaedic implants, and have been following the recent enforcement saga between FDA and J&J/DePuy over custom devices, I would like to ask for your thoughts regarding this particular aspect of the new law.":
Under the relevant sections, general provisions sound "wild."
But under limitations, it is highly restricted as follows.
"...for the purpose of treating a sufficiently rare condition, such that conducting clinical investigations on such device would be impractical..."
"...limited to no more than 5 units per year of a particular device type..."
"...the manufacturer of such device notifies the Secretary on an annual basis..."
However, there may be some leeway (a hole) for an abusive practice. For example, the number "five (5)" might/could/would be interpreted as "5,000" if not 50,000 or more.
Compliance is the key to success!
-------------------------------------------
www.RegulatoryDoctor.com United States
-------------------------------------------
Original Message:
Sent: 07-13-2012 13:10
From: Vineet Sarin
Subject: Custom Device update
The FDA Safety and Innovation Act was signed into law this week and includes amended rules regarding custom devices.
http://www.fda.gov/RegulatoryInformation/Legislation/FederalFoodDrugandCosmeticActFDCAct/SignificantAmendmentstotheFDCAct/FDASIA/default.htm
http://www.gpo.gov/fdsys/pkg/BILLS-112s3187enr/pdf/BILLS-112s3187enr.pdf
(custom devices are discussed in Section 617 [pdf page 70])
To those of you who deal with orthopaedic implants, and have been following the recent enforcement saga between FDA and J&J/DePuy over custom devices, I would like to ask for your thoughts regarding this particular aspect of the new law.
thanks
-------------------------------------------
Vineet Sarin PhD
Camarillo CA
United States
-------------------------------------------